170 related articles for article (PubMed ID: 10514288)
61. In vitro effects of HOE 140 in human bronchial and vascular tissue.
Félétou M; Martin CA; Molimard M; Naline E; Germain M; Thurieau C; Fauchère JL; Canet E; Advenier C
Eur J Pharmacol; 1995 Feb; 274(1-3):57-64. PubMed ID: 7768281
[TBL] [Abstract][Full Text] [Related]
62. New bradykinin analogs in contraction of rat uterus.
Trzeciak HI; Kozik W; Melhem S; Kania A; Dobrowolski D; Prahl A; Derdowska I; Lammek B
Peptides; 2000 Jun; 21(6):829-34. PubMed ID: 10959005
[TBL] [Abstract][Full Text] [Related]
63. Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade.
LeFebvre J; Shintani A; Gebretsadik T; Petro JR; Murphey LJ; Brown NJ
J Pharmacol Exp Ther; 2007 Mar; 320(3):1261-7. PubMed ID: 17182977
[TBL] [Abstract][Full Text] [Related]
64. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
Farmer SG; Burch RM; Dehaas CJ; Togo J; Steranka LR
J Pharmacol Exp Ther; 1989 Feb; 248(2):677-81. PubMed ID: 2537408
[TBL] [Abstract][Full Text] [Related]
65. Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways.
Austin CE; Faussner A; Robinson HE; Chakravarty S; Kyle DJ; Bathon JM; Proud D
J Biol Chem; 1997 Apr; 272(17):11420-5. PubMed ID: 9111052
[TBL] [Abstract][Full Text] [Related]
66. Synthesis and analysis of potent, more lipophilic derivatives of the bradykinin B2 receptor antagonist peptide Hoe 140.
Kennedy KJ; Orwig KS; Dix TA; Christopher J; Jaffa AA
J Pept Res; 2002 Apr; 59(4):139-48. PubMed ID: 11972749
[TBL] [Abstract][Full Text] [Related]
67. New insights into the conformational requirements of B2 bradykinin antagonism.
Filizola M; Llorens O; Cartení-Farina M; Perez JJ
Bioorg Med Chem; 1998 Sep; 6(9):1491-500. PubMed ID: 9801820
[TBL] [Abstract][Full Text] [Related]
68. Autoradiographic analysis of rat brain kinin B1 and B2 receptors: normal distribution and alterations induced by epilepsy.
Ongali B; Campos MM; Bregola G; Rodi D; Regoli D; Thibault G; Simonato M; Couture R
J Comp Neurol; 2003 Jul; 461(4):506-19. PubMed ID: 12746865
[TBL] [Abstract][Full Text] [Related]
69. Inducible bradykinin B1 receptor in isolated human ileum.
Zuzack JS; Burkard MR; Cuadrado DK; Greer RA; Selig WM; Whalley ET
Immunopharmacology; 1996 Jun; 33(1-3):113-5. PubMed ID: 8856127
[No Abstract] [Full Text] [Related]
70. Characterization of des-Arg9-bradykinin-induced contraction in guinea-pig gallbladder in vitro.
Cabrini DA; Calixto JB
Eur J Pharmacol; 1997 Jul; 331(1):31-8. PubMed ID: 9274927
[TBL] [Abstract][Full Text] [Related]
71. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.
Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624
[TBL] [Abstract][Full Text] [Related]
72. Study of the mechanisms involved in the bradykinin-induced contraction of the pig iris sphincter muscle in vitro.
El Sayah M; Calixto JB
Eur J Pharmacol; 2003 Jan; 458(1-2):175-81. PubMed ID: 12498923
[TBL] [Abstract][Full Text] [Related]
73. Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats.
Cloutier F; de Sousa Buck H; Ongali B; Couture R
Br J Pharmacol; 2002 Apr; 135(7):1641-54. PubMed ID: 11934804
[TBL] [Abstract][Full Text] [Related]
74. DesArg10[Hoe 140] is a potent B1 bradykinin antagonist.
Wirth KJ; Wiemer G; Schölkens BA
Agents Actions Suppl; 1992; 38 ( Pt 2)():406-13. PubMed ID: 1334341
[TBL] [Abstract][Full Text] [Related]
75. Receptors for kinins: from classical pharmacology to molecular biology.
Regoli D; Pheng LH; Allogho SN; Nguyen-Le XK; Gobeil F
Immunopharmacology; 1996 Jun; 33(1-3):116-22. PubMed ID: 8856128
[TBL] [Abstract][Full Text] [Related]
76. Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays.
Meini S; Cucchi P; Catalani C; Bellucci F; Giuliani S; Santicioli P; Maggi CA
Eur J Pharmacol; 2009 Aug; 615(1-3):10-6. PubMed ID: 19445925
[TBL] [Abstract][Full Text] [Related]
77. Effect of dexamethasone on cyclophosphamide-induced cystitis in rats: lack of relation with bradykinin B1 receptor-mediated motor responses.
Lecci A; Meini S; Patacchini R; Tramontana M; Giuliani S; Criscuoli M; Maggi CA
Eur J Pharmacol; 1999 Mar; 369(1):99-106. PubMed ID: 10204687
[TBL] [Abstract][Full Text] [Related]
78. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.
Scharfstein J; Schmitz V; Morandi V; Capella MM; Lima AP; Morrot A; Juliano L; Müller-Esterl W
J Exp Med; 2000 Nov; 192(9):1289-300. PubMed ID: 11067878
[TBL] [Abstract][Full Text] [Related]
79. Characterization and localization of bradykinin B2 receptors in the guinea-pig using a radioiodinated HOE140 analogue.
Murone C; Perich RB; Schlawe I; Chai SY; Casley D; MacGregor DP; Müller-Esterl W; Mendelsohn FA
Eur J Pharmacol; 1996 Jun; 306(1-3):237-47. PubMed ID: 8813637
[TBL] [Abstract][Full Text] [Related]
80. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
